National

Man dies in a targeting shooting in Surrey over the weekend

Darpan News Desk Surrey RCMP, 30 Nov, 2020 11:03 PM

One man is dead following a targeted shooting in Surrey on Sunday night. According to Surrey RCMP, officers got reports of a shooting at the Fleetwood shopping complex at the corner of 152 Street and Fraser Highway at around 7:40pm.

Police found the man with serious injuries at the crime scene. He was attended to by paramedics but succumbed to his injuries and was pronounced dead.

IHIT is now engaged in the investigation. The victim is known to police and investigators confirmed this is believed to be a targeted incident.

Prev Next

MORE National ARTICLES

Dozens of people attempt to claim lost cash: RCMP

The Mounties had asked people to refrain from contacting police in attempts to guess those details, warning that their claims would constitute fraud.

Dozens of people attempt to claim lost cash: RCMP

Further lockdowns possible if COVID-19 cases keep rising: Ford

The premier said the lockdowns would be regional, and not mirror the broad approach taken during the first wave of the virus in March.

Further lockdowns possible if COVID-19 cases keep rising: Ford

Experts assess the COVID risks of Halloween

The scaled-back festivities are yet another blow to normal life wrought by the novel coronavirus, bemoans Vicente, who loves the holiday.

Experts assess the COVID risks of Halloween

$10M mark surpassed by Surrey Makes PPE manufacturers

The program’s goal is to ensure that critical PPE is produced, sourced and are readily available to Canadians.

$10M mark surpassed by Surrey Makes PPE manufacturers

MLA Sonia Furstenau wins B.C. Green leadership

Horgan set off election speculation last week when he said the Green party he made an agreement with three years ago that allowed the NDP to form a minority government has changed.

MLA Sonia Furstenau wins B.C. Green leadership

B.C. announces early lung cancer screening program

Premier John Horgan says 70 per cent of all lung cancers are diagnosed at an advanced stage, but the program expected to begin by the spring of 2022 would improve survival rates.